<DOC>
	<DOCNO>NCT01598116</DOCNO>
	<brief_summary>Current treatment option hemangiomas , propranolol , steroid interferon , potential significantly harmful side effect . The purpose study identify potential biomarkers use design clinical trial accelerate delivery new treatment alternative child hemangiomas .</brief_summary>
	<brief_title>A Prospective Longitudinal Study Identify Biomarkers Children With Hemangiomas</brief_title>
	<detailed_description>Urine collect child hemangiomas age-matched healthy control 2,4,6,9,12,18 24 month age . Children hemangioma also ultrasound examination perform visit .</detailed_description>
	<mesh_term>Hemangioma</mesh_term>
	<criteria>Children hemangioma Age ≤ 5 month Doppler ultrasound confirm diagnosis hemangioma rule presence vascular malformation Age match control ≤ 5 month ( hemangioma ) Hemangioma treat prior study period laser , steroid , interferon , propranolol , drug device intend inhibit growth hemangioma Known history sickle cell anemia , thalassemia , hemoglobinopathy Hemangioma present fully form birth consistent rapidly involuting noninvoluting congenital hemangioma PHACES syndrome posterior fossa malformation , hemangioma , arterial anomaly , cardiac anomaly , eye abnormality , sternal anomaly Parent/guardian unable speak english provide inform consent interpreter present</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Months</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>